# Intravenous Magnesium Sulphate in Acute Ischemic Stroke

> **NCT04412850** · EARLY_PHASE1 · UNKNOWN · sponsor: **Dow University of Health Sciences** · enrollment: 44 (estimated)

## Conditions studied

- Stroke
- Ischemic Stroke

## Interventions

- **DRUG:** Magnesium Sulfate

## Key facts

- **NCT ID:** NCT04412850
- **Lead sponsor:** Dow University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04412850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04412850, "Intravenous Magnesium Sulphate in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04412850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*